Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Nivolumab × Genitourinary × Clear all

Phase

Phase 2 93 Phase 1 56 Phase 1/2 43 Phase 3 20 Phase 4 6 Phase EARLY_PHASE1 2 Phase 2/3 2 Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Dermatologic 3 Tumor-Agnostic 1 Thoracic 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 CNS 1 Breast 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Radiosurgery 65 Magnetic Resonance Spectroscopy 42 Standard of Care 37 Exercise 32 Radiotherapy 31 Blood Specimen Collection 25 Early Intervention, Educational 24 Brachytherapy 21 Surveys and Questionnaires 20 Magnetic Resonance Imaging 20 Multiparametric Magnetic Resonance Imaging 17 Methods 17 Androgen Antagonists 17 Therapeutics 16 Interviews as Topic 16 Cystectomy 16 Radiotherapy, Intensity-Modulated 15 Biopsy 14 Psychiatric Rehabilitation 13 Practice Guidelines as Topic 13 Educational Status 13 Specimen Handling 12 Diet Therapy 12 Sunitinib 11 Radiation 11 Resistance Training 10 gallium 68 PSMA-11 9 Surgical Procedures, Operative 9 Prostatectomy 9 Watchful Waiting 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07233668 2025-12-03

IVE in mRCC

Seoul National University Hospital

Phase NA Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡